Michael Mncedisi Willie,
Senior Researcher Council for Medical Schemes
Postdoctoral Research Associate Rosalind Franklin University of Medicine and Science, Green Bay Road,North Chicago
Professor George Perry, Dean and Professor of Biology, College of Sciences University of Texas, United States
Molecular Enzymology and Drug Targets journal aims is to publish the work of designing and synthesis of enzymes and high unmet medical need are based on innovative drug targets. This is an international journal for rapid dissemination of significant data related to enzymes and their use in biotechnology and drug discovery.
The basic enthusiasm of the journal is publishing new data related to the molecular aspects of enzymes, cellular lipid metabolism, biocatalysis, enzyme mechanisms and cellular functions in broader aspects of biology. Molecular Enzymologys interest include in all aspects related to enzymes like discovery of enzymes, enzyme structure, enzyme mechanisms, cellular and metabolic functions of enzymes, exploitation of enzymes for biotechnological and pharmaceutical applications, Enzymology, drug discovery, biochemical aspects of enzymes, bioinformatics, computational analysis, molecular modelling studies, new methods in enzyme expression and purification, biocatalysis, biomolecular engineering, enzyme kinetics and inhibitors. In spite of the great work done in the field of enzymes but there is no specific journal interested in enzymology and in related areas of drug discovery. Therefore, the journal Molecular Enzymology and Drug Targets will be unique in its discipline as it can be the first interest to authors working in the field of enzymology and related subjects.
The journal is an interdisciplinary medium serving several branches of life sciences. This Journals publishes original articles, short communications, notes, and mini reviews. Full length reviews are only published after invitation from the editorial board. Preliminary studies are inappropriate for publishing in Journal of Molecular enzymology and Drug Targets, unless the authors report the significance of their findings, in that case, the manuscript can be accepted. Average first decision of submitted manuscript is expected to be 14 days.
Fast Editorial Execution and Review Process (FEE-Review Process):
Molecular Enzymology and Drug Targets is participating in the Fast Editorial Execution and Review Process (FEE-Review Process) with an additional prepayment of $99 apart from the regular article processing fee. Fast Editorial Execution and Review Process is a special service for the article that enables it to get a faster response in the pre-review stage from the handling editor as well as a review from the reviewer. An author can get a faster response of pre-review maximum in 3 days since submission, and a review process by the reviewer maximum in 5 days, followed by revision/publication in 2 days. If the article gets notified for revision by the handling editor, then it will take another 5 days for external review by the previous reviewer or alternative reviewer.
Acceptance of manuscripts is driven entirely by handling editorial team considerations and independent peer-review, ensuring the highest standards are maintained no matter the route to regular peer-reviewed publication or a fast editorial review process. The handling editor and the article contributor are responsible for adhering to scientific standards. The article FEE-Review process of $99 will not be refunded even if the article is rejected or withdrawn for publication.
The corresponding author or institution/organization is responsible for making the manuscript FEE-Review Process payment. The additional FEE-Review Process payment covers the fast review processing and quick editorial decisions, and regular article publication covers the preparation in various formats for online publication, securing full-text inclusion in a number of permanent archives like HTML, XML, and PDF, and feeding to different indexing agencies.
Articles published in Molecular Enzymology and Drug Targets have been cited by esteemed scholars and scientists all around the world. Molecular Enzymology and Drug Targets has got h-index 5 , which means every article in Molecular Enzymology and Drug Targets has got 5 average citations.